A Bacillus anthracis vaccine strain (Sterne), used as an attenuated laboratory comparative strain, was sequenced and analyzed. A comparison to assemblies of B. anthracis strain Sterne (NZ_CP009541 and NZ_CP009540) was performed. The lack of the pX02 plasmid and pX01 in approximately five copies was confirmed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256644PMC
http://dx.doi.org/10.1128/MRA.00972-18DOI Listing

Publication Analysis

Top Keywords

strain sterne
12
bacillus anthracis
8
anthracis strain
8
draft genome
4
genome sequence
4
sequence bacillus
4
strain
4
sterne 09ra8929
4
09ra8929 bacillus
4
anthracis vaccine
4

Similar Publications

Bacillus cereus biovar anthracis (Bcbva) causes anthrax-like disease in animals, particularly in the non-human primates and great apes of West and Central Africa. Genomic analyses revealed Bcbva as a member of the B. cereus species that carries two plasmids, pBCXO1 and pBCXO2, which have high sequence homology to the B.

View Article and Find Full Text PDF

We present the results of the whole-genome sequencing of a strain isolated from a permafrost sample collected in Yakutia, Russia. This strain was named YakM12. Phylogenetic analysis showed that YakM12 belongs to the canSNP group A.

View Article and Find Full Text PDF

Medicinal plants are rich sources of bioactive compounds with diverse pharmacological properties, including antimicrobial activities. This study aimed to assess the antibiofilm potential of methanol and ethanol extracts from nine selected medicinal plants, as well as their synergistic effects with doxycycline against strains. Standard procedures were employed to determine the phytochemical composition, total phenolic, and flavonoid contents of the extracts.

View Article and Find Full Text PDF

Genetic basis of clarithromycin resistance in .

Microbiol Spectr

June 2024

Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Article Synopsis
  • * Researchers used whole-genome sequencing to identify genetic markers that confer resistance to clarithromycin, an antibiotic used for treating anthrax, by isolating resistant mutants derived from a non-infectious strain.
  • * They discovered specific genetic mutations in the L22 ribosomal protein that were linked to resistance, highlighting the importance of rapid sequencing for understanding and predicting antimicrobial resistance in anthrax.
View Article and Find Full Text PDF

Protective antigen (PA) is a protein produced by Bacillus anthracis. It forms part of the anthrax toxin and is a key immunogen in US and UK anthrax vaccines. In this study, we have conducted experiments to quantify PA in the supernatants of cultures of B.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!